Facebook Instagram Linkedin Youtube
Home Search

Neola Medical - search results

If you're not happy with the results, please do another search

A new chapter for TFS: Nordic expertise, global reach, and a...

Flerie

Lipum looks ahead to phase II with backing from Flerie

Cereno completes CS014 trial ahead of June top-line data

Cereno completes CS014 trial ahead of June top-line data

Trademark

Chordate Medical obtains trademark registration for Ozilia in the US

Dengue

SynAct Pharma’s resomelagon under clinical evaluation for dengue

Lipum

Lipum’s COO brings track record in company building and entrepreneurship

PHI’s acting CEO: ”We aim to drive innovation that accelerates breakthroughs in regenerative medicine”

PHI’s acting CEO: ”We aim to drive innovation that accelerates breakthroughs...

BibbInstruments’ founder on clinical evaluations of EndoDrill GI

Magle Group launches multicenter trial with pancreatic leakage indicator

Magle Group launches multicenter trial with pancreatic leakage indicator

BioStock at Swiss Nordic Bio 2025

Saniona’s new CMO: “More deals are definitely on the horizon”

Saniona’s new CMO: “More deals are definitely on the horizon”

Enzymatica

Enzymatica’s results published in The Journal of Physiology

Sarah Fredriksson, vd Aqilion

Aqilion’s CEO: “We estimate a peak sales potential of a blockbuster magnitude”

CLS

CLS continues toward the goal of becoming cash flow positive by...

Enzymatica boosts Q4 revenue but sees room for stronger partner sales

Saniona’s CEO comments on the recent news

Saniona’s CEO responds to investors’ questions

Chordate

Chordate Medical’s CEO on the rights issue outcome and way forward

Cereno Scientific to evaluate CS1 with advanced imaging technology

SynAct

SynAct Pharma advances trial with boosted funding

Medivir's CEO: "We have attracted interest from the best investigators and hospitals to be part of the phase IIb study"

Medivir’s CEO: “We have attracted interest from the best investigators and...

Q4

Mentice comments on strong Q4 financial performance

Respiratorius continues to improve upon VAL001

Respiratorius continues to improve its offering

Cereno Scientific’s HDAC inhibitor CS014 advances

CLS

CLS presents study results and board changes

Biosergen’s CEO: “These findings open up new possibilities”

Lipum

Double celebration for Lipum

Elicera’s CEO: ”2025 is a crucial year for us”

WntResearch does reverse takeover

WntResearch CEO comments on reverse acquisition

Saniona-backed Cephagenix secures 9 MEUR seed financing

Saniona-backed Cephagenix secures 9 MEUR in seed financing

Chordate

Chordate’s study results published in Neurology

En

Enzymatica recruits experienced marketing director

Lipum

Lipum’s CEO reflects on the year and comments on Eurostars funding

Medivir’s CEO: “The IND approval is a very important milestone”

Medivir’s CEO: “The IND approval is a very important milestone”

2025

Chordate Medical’s CEO looks ahead to 2025: “The exit process is...

USA-expansion i fokus när BioInvent välkomnar ny SVP

US expansion in focus as BioInvent welcomes new SVP

Mentice

“Mentice’s solutions will become even more crucial in the future”, says...

Abliva Q3 2024

From mutation to solution – Abliva gains ground

Saniona’s CEO comments on the recent news

Saniona’s CEO: “The deal with Acadia is significant”

Another successful summit - watch all videos here

Another successful summit – watch all videos here

Curasight

Curasight announces brain cancer as initial target for uTREAT 

Medivir's CEO: “There is an obvious need for fostrox”

Medivir’s CEO: “There is an obvious need for fostrox”

Biosergen’s CEO: “I’m optimistic that we may cure patients”

Cereno Scientific’s CEO on novel therapies for rare diseases

Chordate

Chordate Medical advances to final phase of exit strategy

Lundbeck bids for Longboard Pharmaceuticals

Lundbeck makes huge bid for Longboard

Saniona achieves milestone with Boehringer Ingelheim

Saniona achieves milestone with Boehringer Ingelheim

Prolight

Prolight’s COO: “The pilot line sets the stage for scalability”

Alzinova's new CEO: "The next six months will be really exciting"

Alzinova’s new CEO: “The next six months will be really exciting”

BioStock reports from LSX

BioStock met industry leaders at LSX

Cereno_PhaseIIa_results

Cereno’s phase IIa results positive, clear path forward

Prolight

Point-of-Care in the spotlight at Cardiac Markers Dialogue Meeting

Anders Kronborg

SynAct Pharma’s Chairman: ”We are confident we have the right strategy”

Mentice strengthens cardiology education in Germany through partnership

Most shorted life science stocks

The most shorted life science stocks in the Nordic region

Pia Baumann, CMO Medivir

Medivir – live from ESMO in Barcelona

BioInvent’s CMO comments on the ESMO presentation

BioInvent’s CMO comments on the ESMO presentation

Investing in life science: From Seed to Success 2024

BioInvent makes a strong entrance at ESMO in Barcelona

BioInvent makes a strong entrance at ESMO in Barcelona

Adjutec ready to start phase I

AdjuTec Pharma to start phase I trial with APC148

Glen Davison

Final study results: ColdZyme reduces illness duration and alleviates symptoms

123...13Page 1 of 13
© BioStock 2025